🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

RecruitingNAAges 18 Years - 60 YearsAllUniversity of Texas Southwestern Medical Center
NCT05168605 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients ages 18-60 * Spanish or English speaking * Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record) * Hemoglobin A1C\>8 in last 6 months (based on medical record) * Not pregnant Exclusion Criteria: * Current oral steroid use * History of solid organ transplant * Language other than English or Spanish
💊

What it tests

  • Home visit
📍

Where

1 site
UT Southwestern Medical Center
Dallas, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy